Chemically inducing Bipolar Disorder to create a whole new customer base for the new and high priced atypical antipsychotics is not the least bit difficult when you start patients out on stimulant medications, like Ritalin and antidepressants. That is especially true when given to a young patient with yet growing and developing, and therefore more vulnerable, brain!
“Anti-depressants didn’t help the manic side of Munn’s bipolar disorder. At times his thoughts raced. He didn’t sleep. He had grandiose ideas like how to fix the entire mental health system in the state of Montana.”
“And he believed he could do anything he wanted.”
“’I felt rules didn’t apply to me. That would be grandiosity,’ he said. ‘But they do. And that’s accepting that you have a mental illness’.”
Concerns about the ethics of clinical trials do not exist merely in the realm of speculation. The GVK exposés are not unusual. An increasing number of reports are coming to light of unethical and illegal practices that exploit people’s social and economic vulnerability, subject them to serious risks without their knowledge and consent, and do not even assure them of access to the drugs developed from the trials
I had a bout of hallucinations about 10 years ago. I was suffering quite badly with depression and had been on anti-depressants for years. Then came along Prozac®. The doc thought they would be good so off I went!
The three stages of my hallucinations always happened at night and in bed. I had always been asleep for a while and was awakened by the goings on. They happened in quite quick succession, perhaps over the space of two weeks, then stopped.
Fourth paragraph from the end reads: “Rod Hunt, in mitigation, said his client had been mixing alcohol with anti-depressant tablets, which had made him turn violent.”